January 1, 2001
Ver artículo completoLow-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Methotrexate plus vinblastine given every 7-10 days for several months is associated with prolonged stable disease in a substantial subset of patients with advanced (inoperable) aggressive fibromatosis.